Europäische Union - Isländisch - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatónín - svefntruflun og viðhald - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Europäische Union - Isländisch - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Önnur lyf í taugakerfinu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - azelastinum hýdróklóríð; fluticasonum própíónat - nefúði, dreifa - 137 míkróg / 50 míkróg/skammt

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

alk-abelló a/s - betula verrucosa - stungulyf, dreifa

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

alk-abelló a/s - kattahár - stungulyf, dreifa

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

alk-abelló a/s - dermatophagoides pteronyssinus - stungulyf, dreifa

Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

alk-abelló a/s - hundahár - stungulyf, dreifa